During the past decade, Poplar Bluff Urology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Poplar Bluff Urology" are "Overactive Bladder" (3 trials). Many other conditions were trialed in "Poplar Bluff Urology" in a lesser frequency.

Most popular intervention types in "Poplar Bluff Urology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Vibegron" (2 trials), "Placebo" (1 trials), "Tolterodine Tartrate ER" (1 trials), "Tolterodine placebo" (1 trials) and "Vibegron placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Poplar Bluff Urology" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Poplar Bluff Urology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Poplar Bluff Urology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Poplar Bluff Urology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".